Source:http://linkedlifedata.com/resource/pubmed/id/11279683
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2001-3-30
|
pubmed:abstractText |
Tardive dyskinesia (TD) is a potentially disfiguring movement disorder of the orofacial region often caused by use of neuroleptic drugs. A wide range of strategies has been used to help manage TD and, for those who are unable to have their antipsychotic medication stopped or substantially changed, the calcium-channel blocking group of drugs (diltiazem, nifedipine, nimodipine, verapamil) has been suggested as a useful adjunctive treatment.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1469-493X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
CD000206
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11279683-Antipsychotic Agents,
pubmed-meshheading:11279683-Calcium Channel Blockers,
pubmed-meshheading:11279683-Dyskinesia, Drug-Induced,
pubmed-meshheading:11279683-Humans,
pubmed-meshheading:11279683-Randomized Controlled Trials as Topic,
pubmed-meshheading:11279683-Schizophrenia
|
pubmed:year |
2001
|
pubmed:articleTitle |
Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
|
pubmed:affiliation |
Dov Hoz Street, 27/16, Kfar Saba, ISRAEL, 44356. ksoares@netvision.net.il
|
pubmed:publicationType |
Journal Article,
Review
|